ClinicalTrials.Veeva

Menu

Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief

A

Ain Shams University

Status and phase

Completed
Phase 3
Phase 2

Conditions

Obstetric Pain

Treatments

Drug: Wound infiltration by Bupivacaine
Drug: Wound infiltration by Pethidine

Study type

Interventional

Funder types

Other

Identifiers

NCT03652116
PostCSLA

Details and patient eligibility

About

The aim of this study is to compare between the effect of wound infiltration with bupivacaine or pethidine for post cesarean section pain relief.

Enrollment

78 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mode of delivery: Cesarean section.
  • Gestational age: 37-40 weeks.
  • Type of anaesthesia: Spinal anaesthesia.
  • No past history of any medical disorder or other medical complications during pregnancy.

Exclusion criteria

  • Women with known hypersensitivity to bupivacaine or pethidine.
  • Women delivered vaginally.
  • Women delivered under general anaesthesia.
  • Women with known neurological or psychological disease.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

78 participants in 2 patient groups

Bupivacaine Group
Active Comparator group
Description:
Patients delivered by cesarean section followed by wound infiltration by bupivacaine.
Treatment:
Drug: Wound infiltration by Bupivacaine
Pethidine Group
Active Comparator group
Description:
Patients delivered by cesarean section followed by wound infiltration by pethidine.
Treatment:
Drug: Wound infiltration by Pethidine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems